1
|
Hájek M, Flögel U, S Tavares AA, Nichelli L, Kennerley A, Kahn T, Futterer JJ, Firsiori A, Grüll H, Saha N, Couñago F, Aydogan DB, Caligiuri ME, Faber C, Bell LC, Figueiredo P, Vilanova JC, Santini F, Mekle R, Waiczies S. MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention. MAGMA (NEW YORK, N.Y.) 2024:10.1007/s10334-024-01176-5. [PMID: 38865057 DOI: 10.1007/s10334-024-01176-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2024] [Revised: 04/26/2024] [Accepted: 04/30/2024] [Indexed: 06/13/2024]
Affiliation(s)
- Milan Hájek
- Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Ulrich Flögel
- Experimental Cardiovascular Imaging, Institute for Molecular Cardiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | - Adriana A S Tavares
- Centre for Cardiovascular Sciences and Edinburgh Imaging, University of Edinburgh, Edinburgh, UK
| | - Lucia Nichelli
- Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute, ICM, Paris, France
- Department of Neuroradiology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
| | - Aneurin Kennerley
- Department of Sports and Exercise Science, Institute of Sport, Manchester Metropolitan University, Manchester, UK
- Department of Biology, University of York, York, UK
| | - Thomas Kahn
- Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany
| | - Jurgen J Futterer
- Minimally Invasive Image-Guided Intervention Center (MAGIC), Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands
| | - Aikaterini Firsiori
- Unit of Diagnostic and Interventional Neuroradiology, Diagnostic Department, University Hospitals of Geneva, Geneva, Switzerland
| | - Holger Grüll
- Institute of Diagnostic and Interventional Radiology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, University of Cologne, Cologne, Germany
| | - Nandita Saha
- Max-Delbrück-Centrum Für Molekulare Medizin (MDC), Berlin Ultrahigh Field Facility, Berlin, Germany
- Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Felipe Couñago
- Department of Radiation Oncology, Hospital Universitario San Francisco de Asís, Hospital Universitario Vithas La Milagrosa, GenesisCare, 28010, Madrid, Spain
| | - Dogu Baran Aydogan
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
| | - Maria Eugenia Caligiuri
- Neuroscience Research Center, Department of Medical and Surgical Sciences, Università Degli Studi "Magna Graecia", Catanzaro, Italy
| | - Cornelius Faber
- Translational Research Imaging Center (TRIC), Clinic of Radiology, University of Münster, Münster, Germany
| | - Laura C Bell
- Early Clinical Development, Genentech Inc., South San Francisco, USA
| | - Patrícia Figueiredo
- Institute for Systems and Robotics, ISR-Lisboa, Lisbon, Portugal
- Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal
| | - Joan C Vilanova
- Department of Radiology, Clínica Girona, Institute of Diagnostic Imaging (IDI) Girona, University of Girona, 17004, Girona, Spain
| | - Francesco Santini
- Department of Radiology, University Hospital of Basel, Basel, Switzerland
- Basel Muscle MRI, Department of Biomedical Engineering, University of Basel, Basel, Switzerland
| | - Ralf Mekle
- Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Sonia Waiczies
- Max-Delbrück-Centrum Für Molekulare Medizin (MDC), Berlin Ultrahigh Field Facility, Berlin, Germany.
- Experimental and Clinical Research Center (ECRC), A Joint Cooperation Between the Charité Medical Faculty and the MDC, Berlin, Germany.
| |
Collapse
|
2
|
Woo MK, DelaBarre L, Waks M, Lagore R, Kim J, Jungst S, Eryaman Y, Ugurbil K, Adriany G. A 32-Channel Sleeve Antenna Receiver Array for Human Head MRI Applications at 10.5 T. IEEE TRANSACTIONS ON MEDICAL IMAGING 2023; 42:2643-2652. [PMID: 37030782 DOI: 10.1109/tmi.2023.3261922] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/19/2023]
Abstract
For human brain magnetic resonance imaging (MRI), high channel count ( ≥ 32 ) radiofrequency receiver coil arrays are utilized to achieve maximum signal-to-noise ratio (SNR) and to accelerate parallel imaging techniques. With ultra-high field (UHF) MRI at 7 tesla (T) and higher, dipole antenna arrays have been shown to generate high SNR in the deep regions of the brain, however the array elements exhibit increased electromagnetic coupling with one another, making array construction more difficult with the increasing number of elements. Compared to a classical dipole antenna array, a sleeve antenna array incorporates the coaxial ground into the feed-point, resulting in a modified asymmetric antenna structure with improved intra-element decoupling. Here, we extended our previous 16-channel sleeve transceiver work and developed a 32-channel azimuthally arranged sleeve antenna receive-only array for 10.5 T human brain imaging. We experimentally compared the achievable SNR of the sleeve antenna array at 10.5 T to a more traditional 32-channel loop array bult onto a human head-shaped former. The results obtained with a head shaped phantom clearly demonstrated that peripheral intrinsic SNR can be significantly improved compared to a loop array with the same number of elements- except for the superior part of the phantom where sleeve antenna elements are not located.
Collapse
|
3
|
Torres F, Basaran AC, Schuller IK. Thermal Management in Neuromorphic Materials, Devices, and Networks. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2023; 35:e2205098. [PMID: 36067752 DOI: 10.1002/adma.202205098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 08/30/2022] [Indexed: 06/15/2023]
Abstract
Machine learning has experienced unprecedented growth in recent years, often referred to as an "artificial intelligence revolution." Biological systems inspire the fundamental approach for this new computing paradigm: using neural networks to classify large amounts of data into sorting categories. Current machine-learning schemes implement simulated neurons and synapses on standard computers based on a von Neumann architecture. This approach is inefficient in energy consumption, and thermal management, motivating the search for hardware-based systems that imitate the brain. Here, the present state of thermal management of neuromorphic computing technology and the challenges and opportunities of the energy-efficient implementation of neuromorphic devices are considered. The main features of brain-inspired computing and quantum materials for implementing neuromorphic devices are briefly described, the brain criticality and resistive switching-based neuromorphic devices are discussed, the energy and electrical considerations for spiking-based computation are presented, the fundamental features of the brain's thermal regulation are addressed, the physical mechanisms for thermal management and thermoelectric control of materials and neuromorphic devices are analyzed, and challenges and new avenues for implementing energy-efficient computing are described.
Collapse
Affiliation(s)
- Felipe Torres
- Physics Department, Faculty of Science, University of Chile, 653, Santiago, 7800024, Chile
- Center of Nanoscience and Nanotechnology (CEDENNA), Av. Ecuador 3493, Santiago, 9170124, Chile
| | - Ali C Basaran
- Department of Physics and Center for Advanced Nanoscience, University of California San Diego, La Jolla, CA, 92093, USA
| | - Ivan K Schuller
- Department of Physics and Center for Advanced Nanoscience, University of California San Diego, La Jolla, CA, 92093, USA
| |
Collapse
|
4
|
Salarinejad A, Esmaeilpour K, Shabani M, Jafarinejad-Farsangi S, Pardakhty A, Asadi-Shekaari M, Ahmadi-Zeidabadi M. Effect of l-Dopa in acute temozolomide-induced cognitive impairment in male mice: a possible antineuroinflammatory role. Behav Pharmacol 2023:00008877-990000000-00047. [PMID: 37401406 DOI: 10.1097/fbp.0000000000000733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/05/2023]
Abstract
Temozolomide is used commonly in the treatment of some types of cancers, but it may also result in cognitive impairments such as memory deficits. l-Dopa, a well known medicine for the central nervous system, has been shown to have positive effects on some cognitive disorders. Here we sought to investigate the effect of l-Dopa on temozolomide-induced cognitive impairments. BALB/c mice were subjected to 3-days temozolomide and 6-days concomitant l-Dopa/benserazide administration in six groups (control, l-Dopa 25 mg/kg, l-Dopa 75 mg/kg, temozolomide, temozolomide + l-Dopa 25 mg/kg, and temozolomide + l-Dopa 75 mg/kg). Open field test, object location recognition, novel object recognition test, and shuttle-box test were carried out to determine the locomotor, anxiety-like behavior, and memory function of subjects. TNF-α and brain-derived neurotrophic factor (BDNF) gene expression in the hippocampus was measured by real-time PCR. Mice treated with temozolomide showed recognition memory impairment, along with hippocampal TNF-α and BDNF mRNA expression level raise, and detection of histological insults in hematoxylin and eosin hippocampal slides. Mice that received temozolomide + l-Dopa showed normal behavioral function and lower TNF-α and BDNF hippocampal mRNA expression levels, and histologically normal hippocampal CA1 region in comparison with mice in the temozolomide group. Our results provide evidence that l-Dopa prevents temozolomide-induced recognition memory deficit in mice at the acute phase probably via l-Dopa antineuroinflammatory effects.
Collapse
Affiliation(s)
| | | | | | | | - Abbas Pardakhty
- Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran
| | | | | |
Collapse
|
5
|
Schmidt R, Keban E, Bollmann S, Wiggins CJ, Niendorf T. Scaling the mountains: what lies above 7 Tesla magnetic resonance? MAGMA (NEW YORK, N.Y.) 2023; 36:151-157. [PMID: 37072540 PMCID: PMC10140119 DOI: 10.1007/s10334-023-01087-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/27/2023] [Indexed: 04/20/2023]
Affiliation(s)
- Rita Schmidt
- Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
| | - Elena Keban
- Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland
| | - Saskia Bollmann
- School of Information Technology and Electrical Engineering, Faculty of Engineering, Architecture and Information Technology, The University of Queensland, Brisbane, Australia
| | - Christopher J Wiggins
- Imaging Core Facility, Institute for Neurology and Medicine, Forschungszentrum Julich, Julich, Germany
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
| |
Collapse
|
6
|
Nurzed B, Kuehne A, Aigner CS, Schmitter S, Niendorf T, Eigentler TW. Radiofrequency antenna concepts for human cardiac MR at 14.0 T. MAGMA (NEW YORK, N.Y.) 2023; 36:257-277. [PMID: 36920549 PMCID: PMC10140016 DOI: 10.1007/s10334-023-01075-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 02/23/2023] [Accepted: 02/27/2023] [Indexed: 04/28/2023]
Abstract
OBJECTIVE To examine the feasibility of human cardiac MR (CMR) at 14.0 T using high-density radiofrequency (RF) dipole transceiver arrays in conjunction with static and dynamic parallel transmission (pTx). MATERIALS AND METHODS RF arrays comprised of self-grounded bow-tie (SGBT) antennas, bow-tie (BT) antennas, or fractionated dipole (FD) antennas were used in this simulation study. Static and dynamic pTx were applied to enhance transmission field (B1+) uniformity and efficiency in the heart of the human voxel model. B1+ distribution and maximum specific absorption rate averaged over 10 g tissue (SAR10g) were examined at 7.0 T and 14.0 T. RESULTS At 14.0 T static pTx revealed a minimum B1+ROI efficiency of 0.91 μT/√kW (SGBT), 0.73 μT/√kW (BT), and 0.56 μT/√kW (FD) and maximum SAR10g of 4.24 W/kg, 1.45 W/kg, and 2.04 W/kg. Dynamic pTx with 8 kT points indicate a balance between B1+ROI homogeneity (coefficient of variation < 14%) and efficiency (minimum B1+ROI > 1.11 µT/√kW) at 14.0 T with a maximum SAR10g < 5.25 W/kg. DISCUSSION MRI of the human heart at 14.0 T is feasible from an electrodynamic and theoretical standpoint, provided that multi-channel high-density antennas are arranged accordingly. These findings provide a technical foundation for further explorations into CMR at 14.0 T.
Collapse
Affiliation(s)
- Bilguun Nurzed
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), Robert Rössle Strasse 10, 13125, Berlin, Germany
| | | | | | | | - Thoralf Niendorf
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), Robert Rössle Strasse 10, 13125, Berlin, Germany.
- MRI.TOOLS GmbH, Berlin, Germany.
- Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
| | - Thomas Wilhelm Eigentler
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), Robert Rössle Strasse 10, 13125, Berlin, Germany
- Chair of Medical Engineering, Technische Universität Berlin, Berlin, Germany
| |
Collapse
|
7
|
Sumser K, Drizdal T, Bellizzi GG, Hernandez-Tamames JA, van Rhoon GC, Paulides MM. Experimental Validation of the MRcollar: An MR Compatible Applicator for Deep Heating in the Head and Neck Region. Cancers (Basel) 2021; 13:5617. [PMID: 34830773 PMCID: PMC8615935 DOI: 10.3390/cancers13225617] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 10/29/2021] [Accepted: 11/08/2021] [Indexed: 12/13/2022] Open
Abstract
Clinical effectiveness of hyperthermia treatments, in which tumor tissue is artificially heated to 40-44 °C for 60-90 min, can be hampered by a lack of accurate temperature monitoring. The need for noninvasive temperature monitoring in the head and neck region (H&N) and the potential of MR thermometry prompt us to design an MR compatible hyperthermia applicator: the MRcollar. In this work, we validate the design, numerical model, and MR performance of the MRcollar. The MRcollar antennas have low reflection coefficients (<-15 dB) and the intended low interaction between the individual antenna modules (<-32 dB). A 10 °C increase in 3 min was reached in a muscle-equivalent phantom, such that the specifications from the European Society for Hyperthermic Oncology were easily reached. The MRcollar had a minimal effect on MR image quality and a five-fold improvement in SNR was achieved using the integrated coils of the MRcollar, compared to the body coil. The feasibility of using the MRcollar in an MR environment was shown by a synchronous heating experiment. The match between the predicted SAR and measured SAR using MR thermometry satisfied the gamma criteria [distance-to-agreement = 5 mm, dose-difference = 7%]. All experiments combined show that the MRcollar delivers on the needs for MR-hyperthermia in the H&N and is ready for in vivo investigation.
Collapse
Affiliation(s)
- Kemal Sumser
- Department of Radiotherapy, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands; (T.D.); (G.G.B.); (G.C.v.R.); (M.M.P.)
| | - Tomas Drizdal
- Department of Radiotherapy, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands; (T.D.); (G.G.B.); (G.C.v.R.); (M.M.P.)
- Department of Biomedical Technology, Czech Technical University in Prague, nam. Sítna 3105, 272 01 Kladno, Czech Republic
| | - Gennaro G. Bellizzi
- Department of Radiotherapy, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands; (T.D.); (G.G.B.); (G.C.v.R.); (M.M.P.)
| | - Juan A. Hernandez-Tamames
- Department of Radiology and Nuclear Medicine, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands;
| | - Gerard C. van Rhoon
- Department of Radiotherapy, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands; (T.D.); (G.G.B.); (G.C.v.R.); (M.M.P.)
| | - Margarethus Marius Paulides
- Department of Radiotherapy, Erasmus Medical Center Cancer Institute, 3015 GD Rotterdam, The Netherlands; (T.D.); (G.G.B.); (G.C.v.R.); (M.M.P.)
- Department of Electrical Engineering, Eindhoven University of Technology, 5612 AZ Eindhoven, The Netherlands
| |
Collapse
|
8
|
Eigentler TW, Kuehne A, Boehmert L, Dietrich S, Els A, Waiczies H, Niendorf T. 32-Channel self-grounded bow-tie transceiver array for cardiac MR at 7.0T. Magn Reson Med 2021; 86:2862-2879. [PMID: 34169546 DOI: 10.1002/mrm.28885] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Revised: 04/20/2021] [Accepted: 05/18/2021] [Indexed: 12/17/2022]
Abstract
PURPOSE Design, implementation, evaluation, and application of a 32-channel Self-Grounded Bow-Tie (SGBT) transceiver array for cardiac MR (CMR) at 7.0T. METHODS The array consists of 32 compact SGBT building blocks. Transmission field ( B 1 + ) shimming and radiofrequency safety assessment were performed with numerical simulations and benchmarked against phantom experiments. In vivo B 1 + efficiency mapping was conducted with actual flip angle imaging. The array's applicability for accelerated high spatial resolution 2D FLASH CINE imaging of the heart was examined in a volunteer study (n = 7). RESULTS B 1 + shimming provided a uniform field distribution suitable for female and male subjects. Phantom studies demonstrated an excellent agreement between simulated and measured B 1 + efficiency maps (7% mean difference). The SGBT array afforded a spatial resolution of (0.8 × 0.8 × 2.5) mm3 for 2D CINE FLASH which is by a factor of 12 superior to standardized cardiovascular MR (CMR) protocols. The density of the SGBT array supports 1D acceleration of up to R = 4 (mean signal-to-noise ratio (whole heart) ≥ 16.7, mean contrast-to-noise ratio ≥ 13.5) without impairing image quality significantly. CONCLUSION The compact SGBT building block facilitates a modular high-density array that supports accelerated and high spatial resolution CMR at 7.0T. The array provides a technological basis for future clinical assessment of parallel transmission techniques.
Collapse
Affiliation(s)
- Thomas Wilhelm Eigentler
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.,Chair of Medical Engineering, Technische Universität Berlin, Berlin, Germany
| | | | - Laura Boehmert
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Sebastian Dietrich
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany
| | - Antje Els
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | | | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.,MRI.TOOLS GmbH, Berlin, Germany.,Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| |
Collapse
|
9
|
Drizdal T, Sumser K, Bellizzi GG, Fiser O, Vrba J, Rhoon GCV, Yeo DTB, Margarethus M Paulides. Simulation guided design of the MRcollar: a MR compatible applicator for deep heating in the head and neck region. Int J Hyperthermia 2021; 38:382-392. [PMID: 33682594 DOI: 10.1080/02656736.2021.1892836] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
PURPOSE To develop a head and neck hyperthermia phased array system compatible with a 1.5 T magnetic resonance (MR) scanner for noninvasive thermometry. METHODS We designed a dielectric-parabolic-reflector antenna (DiPRA) based on a printed reflector backed dipole antenna and studied its predicted and measured performance in a flat configuration (30 mm thick water bolus and muscle equivalent layer). Thereafter, we designed a phased array applicator model ('MRcollar') consisting of 12 DiPRA modules placed on a radius of 180 mm. Theoretical heating performance of the MRcollar model was benchmarked against the current clinical applicator (HYPERcollar3D) using specific (3D) head and neck models of 28 treated patients. Lastly, we assessed the influence of the DiPRA modules on MR scanning quality. RESULTS The predicted and measured reflection coefficients (S11) of the DiPRA module are below -20 dB. The maximum specific absorption rate (SAR) in the area under the antenna was 47% higher than for the antenna without encasing. Compared to the HYPERcollar3D, the MRcollar design incorporates 31% less demineralized water (-2.5 L), improves the predicted TC25 (target volume enclosed by 25% iso-SAR contour) by 4.1% and TC50 by 8.5%, while the target-to-hotspot quotient (THQ) is minimally affected (-1.6%). MR experiments showed that the DiPRA modules do not affect MR transmit/receive performance. CONCLUSION Our results suggest that head and neck hyperthermia delivery quality with the MRcollar can be maintained, while facilitating simultaneous noninvasive MR thermometry for treatment monitoring and control.
Collapse
Affiliation(s)
- Tomas Drizdal
- Hyperthermia Unit, Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.,Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, Kladno, Czech Republic in Prague
| | - Kemal Sumser
- Hyperthermia Unit, Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - Gennaro G Bellizzi
- Hyperthermia Unit, Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.,Department of Information Engineering, Infrastructures and Sustainable Energy, Universita Mediterranea di Reggio Calabria, Reggio di Calabria, Italy
| | - Ondrej Fiser
- Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, Kladno, Czech Republic in Prague
| | - Jan Vrba
- Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, Kladno, Czech Republic in Prague
| | - Gerard C van Rhoon
- Hyperthermia Unit, Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - Desmond T B Yeo
- Imaging and Bioelectronic Technologies, GE Global Research Centre, Niskayuna, NY, USA
| | - Margarethus M Paulides
- Hyperthermia Unit, Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.,Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
| |
Collapse
|
10
|
Abstract
Time-reversal (TR) is a known wideband array beam-forming technique that has been suggested as a treatment planning alternative in deep microwave hyperthermia for cancer treatment. While the aim in classic TR is to focus the energy at a specific point within the target, no assumptions are made on secondary lobes that might arise in the healthy tissues. These secondary lobes, together with tissue heterogeneity, may result in hot-spots (HSs), which are known to limit the efficiency of the thermal dose delivery to the tumor. This paper proposes a novel wideband TR focusing method that iteratively shifts the focus away from HSs and towards cold-spots from an initial TR solution, a procedure that improves tumor coverage and reduces HSs. We verify this method on two different applicator topologies and several target volume configurations. The algorithm is deterministic and runs within seconds, enabling its use for real-time applications. At the same time, it yields results comparable to those obtained with global stochastic optimizers such as Particle Swarm.
Collapse
Affiliation(s)
- Massimiliano Zanoli
- Dept. Electrical Engineering, Chalmers University of Technology, Gothenburg, SE, Sweden
| | - Hana Dobšíček Trefná
- Dept. Electrical Engineering, Chalmers University of Technology, Gothenburg, SE, Sweden
| |
Collapse
|
11
|
Adibzadeh F, Sumser K, Curto S, Yeo DTB, Shishegar AA, Paulides MM. Systematic review of pre-clinical and clinical devices for magnetic resonance-guided radiofrequency hyperthermia. Int J Hyperthermia 2020; 37:15-27. [PMID: 31918599 DOI: 10.1080/02656736.2019.1705404] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Clinical trials have demonstrated the therapeutic benefits of adding radiofrequency (RF) hyperthermia (HT) as an adjuvant to radio- and chemotherapy. However, maximum utilization of these benefits is hampered by the current inability to maintain the temperature within the desired range. RF HT treatment quality is usually monitored by invasive temperature sensors, which provide limited data sampling and are prone to infection risks. Magnetic resonance (MR) temperature imaging has been developed to overcome these hurdles by allowing noninvasive 3D temperature monitoring in the target and normal tissues. To exploit this feature, several approaches for inserting the RF heating devices into the MR scanner have been proposed over the years. In this review, we summarize the status quo in MR-guided RF HT devices and analyze trends in these hybrid hardware configurations. In addition, we discuss the various approaches, extract best practices and identify gaps regarding the experimental validation procedures for MR - RF HT, aimed at converging to a common standard in this process.
Collapse
Affiliation(s)
- Fatemeh Adibzadeh
- Department of Radiation Oncology, Erasmus MC - Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.,Department of Electrical Engineering, Technical University of Sharif, Tehran, Iran
| | - Kemal Sumser
- Department of Radiation Oncology, Erasmus MC - Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Sergio Curto
- Department of Radiation Oncology, Erasmus MC - Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | | | - Amir A Shishegar
- Department of Electrical Engineering, Technical University of Sharif, Tehran, Iran
| | - Margarethus M Paulides
- Department of Radiation Oncology, Erasmus MC - Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.,Department of Electrical Engineering, Technical University of Eindhoven, Eindhoven, The Netherlands
| |
Collapse
|
12
|
Winter L, Silemek B, Petzold J, Pfeiffer H, Hoffmann W, Seifert F, Ittermann B. Parallel transmission medical implant safety testbed: Real‐time mitigation of RF induced tip heating using time‐domain E‐field sensors. Magn Reson Med 2020; 84:3468-3484. [DOI: 10.1002/mrm.28379] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Revised: 05/19/2020] [Accepted: 05/22/2020] [Indexed: 12/15/2022]
Affiliation(s)
- Lukas Winter
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Berk Silemek
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Johannes Petzold
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Harald Pfeiffer
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Werner Hoffmann
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Frank Seifert
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Bernd Ittermann
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| |
Collapse
|
13
|
Han H, Eigentler TW, Wang S, Kretov E, Winter L, Hoffmann W, Grass E, Niendorf T. Design, Implementation, Evaluation and Application of a 32-Channel Radio Frequency Signal Generator for Thermal Magnetic Resonance Based Anti-Cancer Treatment. Cancers (Basel) 2020; 12:cancers12071720. [PMID: 32605322 PMCID: PMC7408155 DOI: 10.3390/cancers12071720] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 06/21/2020] [Accepted: 06/22/2020] [Indexed: 12/13/2022] Open
Abstract
Thermal Magnetic Resonance (ThermalMR) leverages radio frequency (RF)-induced heating to examine the role of temperature in biological systems and disease. To advance RF heating with multi-channel RF antenna arrays and overcome the shortcomings of current RF signal sources, this work reports on a 32-channel modular signal generator (SGPLL). The SGPLL was designed around phase-locked loop (PLL) chips and a field-programmable gate array chip. To examine the system properties, switching/settling times, accuracy of RF power level and phase shifting were characterized. Electric field manipulation was successfully demonstrated in deionized water. RF heating was conducted in a phantom setup using self-grounded bow-tie RF antennae driven by the SGPLL. Commercial signal generators limited to a lower number of RF channels were used for comparison. RF heating was evaluated with numerical temperature simulations and experimentally validated with MR thermometry. Numerical temperature simulations and heating experiments controlled by the SGPLL revealed the same RF interference patterns. Upon RF heating similar temperature changes across the phantom were observed for the SGPLL and for the commercial devices. To conclude, this work presents the first 32-channel modular signal source for RF heating. The large number of coherent RF channels, wide frequency range and accurate phase shift provided by the SGPLL form a technological basis for ThermalMR controlled hyperthermia anti-cancer treatment.
Collapse
Affiliation(s)
- Haopeng Han
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (H.H.); (T.W.E.); (E.K.)
- Humboldt-Universität zu Berlin, Institute of Computer Science, 10099 Berlin, Germany;
| | - Thomas Wilhelm Eigentler
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (H.H.); (T.W.E.); (E.K.)
- Technische Universität Berlin, Chair of Medical Engineering, 10623 Berlin, Germany
| | - Shuailin Wang
- Beijing Deepvision Technology Co., Ltd., Beijing 100085, China;
| | - Egor Kretov
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (H.H.); (T.W.E.); (E.K.)
| | - Lukas Winter
- Physikalisch-Technische Bundesanstalt (PTB), 10587 Berlin, Germany; (L.W.); (W.H.)
| | - Werner Hoffmann
- Physikalisch-Technische Bundesanstalt (PTB), 10587 Berlin, Germany; (L.W.); (W.H.)
| | - Eckhard Grass
- Humboldt-Universität zu Berlin, Institute of Computer Science, 10099 Berlin, Germany;
- IHP—Leibniz-Institut für innovative Mikroelektronik, 15236 Frankfurt (Oder), Germany
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (H.H.); (T.W.E.); (E.K.)
- Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
- MRI.TOOLS GmbH, 13125 Berlin, Germany
- Correspondence: ; Tel.: +49-30-9406-4505
| |
Collapse
|
14
|
Ji Y, Winter L, Navarro L, Ku MC, Periquito JS, Pham M, Hoffmann W, Theune LE, Calderón M, Niendorf T. Controlled Release of Therapeutics from Thermoresponsive Nanogels: A Thermal Magnetic Resonance Feasibility Study. Cancers (Basel) 2020; 12:cancers12061380. [PMID: 32471299 PMCID: PMC7352924 DOI: 10.3390/cancers12061380] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 05/23/2020] [Accepted: 05/25/2020] [Indexed: 12/16/2022] Open
Abstract
Thermal magnetic resonance (ThermalMR) accommodates radio frequency (RF)-induced temperature modulation, thermometry, anatomic and functional imaging, and (nano)molecular probing in an integrated RF applicator. This study examines the feasibility of ThermalMR for the controlled release of a model therapeutics from thermoresponsive nanogels using a 7.0-tesla whole-body MR scanner en route to local drug-delivery-based anticancer treatments. The capacity of ThermalMR is demonstrated in a model system involving the release of fluorescein-labeled bovine serum albumin (BSA-FITC, a model therapeutic) from nanometer-scale polymeric networks. These networks contain thermoresponsive polymers that bestow environmental responsiveness to physiologically relevant changes in temperature. The release profile obtained for the reference data derived from a water bath setup used for temperature stimulation is in accordance with the release kinetics deduced from the ThermalMR setup. In conclusion, ThermalMR adds a thermal intervention dimension to an MRI device and provides an ideal testbed for the study of the temperature-induced release of drugs, magnetic resonance (MR) probes, and other agents from thermoresponsive carriers. Integrating diagnostic imaging, temperature intervention, and temperature response control, ThermalMR is conceptually appealing for the study of the role of temperature in biology and disease and for the pursuit of personalized therapeutic drug delivery approaches for better patient care.
Collapse
Affiliation(s)
- Yiyi Ji
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (Y.J.); (M.-C.K.); (J.S.P.); (M.P.)
| | - Lukas Winter
- Physikalisch-Technische Bundesanstalt (PTB), 10587 Berlin, Germany; (L.W.); (W.H.)
| | - Lucila Navarro
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, 14195 Berlin, Germany; (L.N.); (L.E.T.); (M.C.)
- Instituto de Desarrollo Tecnológico para la Industria Química (INTEC), Universidad Nacional del Litoral (UNL)—Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Santa Fe 3000, Argentina
| | - Min-Chi Ku
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (Y.J.); (M.-C.K.); (J.S.P.); (M.P.)
| | - João S. Periquito
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (Y.J.); (M.-C.K.); (J.S.P.); (M.P.)
| | - Michal Pham
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (Y.J.); (M.-C.K.); (J.S.P.); (M.P.)
| | - Werner Hoffmann
- Physikalisch-Technische Bundesanstalt (PTB), 10587 Berlin, Germany; (L.W.); (W.H.)
| | - Loryn E. Theune
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, 14195 Berlin, Germany; (L.N.); (L.E.T.); (M.C.)
| | - Marcelo Calderón
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, 14195 Berlin, Germany; (L.N.); (L.E.T.); (M.C.)
- POLYMAT and Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, 20018 Donostia-San Sebastián, Spain
- IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; (Y.J.); (M.-C.K.); (J.S.P.); (M.P.)
- Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
- Correspondence: ; Tel.: +49-30-9406-4505
| |
Collapse
|
15
|
Eigentler TW, Winter L, Han H, Oberacker E, Kuehne A, Waiczies H, Schmitter S, Boehmert L, Prinz C, Trefna HD, Niendorf T. Wideband Self-Grounded Bow-Tie Antenna for Thermal MR. NMR IN BIOMEDICINE 2020; 33:e4274. [PMID: 32078208 DOI: 10.1002/nbm.4274] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 01/07/2020] [Accepted: 01/27/2020] [Indexed: 06/10/2023]
Abstract
The objective of this study was the design, implementation, evaluation and application of a compact wideband self-grounded bow-tie (SGBT) radiofrequency (RF) antenna building block that supports anatomical proton (1 H) MRI, fluorine (19 F) MRI, MR thermometry and broadband thermal intervention integrated in a whole-body 7.0 T system. Design considerations and optimizations were conducted with numerical electromagnetic field (EMF) simulations to facilitate a broadband thermal intervention frequency of the RF antenna building block. RF transmission (B1+ ) field efficiency and specific absorption rate (SAR) were obtained in a phantom, and the thigh of human voxel models (Ella, Duke) for 1 H and 19 F MRI at 7.0 T. B1+ efficiency simulations were validated with actual flip-angle imaging measurements. The feasibility of thermal intervention was examined by temperature simulations (f = 300, 400 and 500 MHz) in a phantom. The RF heating intervention (Pin = 100 W, t = 120 seconds) was validated experimentally using the proton resonance shift method and fiberoptic probes for temperature monitoring. The applicability of the SGBT RF antenna building block for in vivo 1 H and 19 F MRI was demonstrated for the thigh and forearm of a healthy volunteer. The SGBT RF antenna building block facilitated 19 F and 1 H MRI at 7.0 T as well as broadband thermal intervention (234-561 MHz). For the thigh of the human voxel models, a B1+ efficiency ≥11.8 μT/√kW was achieved at a depth of 50 mm. Temperature simulations and heating experiments in a phantom demonstrated a temperature increase ΔT >7 K at a depth of 10 mm. The compact SGBT antenna building block provides technology for the design of integrated high-density RF applicators and for the study of the role of temperature in (patho-) physiological processes by adding a thermal intervention dimension to an MRI device (Thermal MR).
Collapse
Affiliation(s)
- Thomas Wilhelm Eigentler
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Technische Universität Berlin, Chair of Medical Engineering, Berlin, Germany
| | - Lukas Winter
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany
| | - Haopeng Han
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Institute of Computer Science, Humboldt-Universitätzu Berlin, Berlin, Germany
| | - Eva Oberacker
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | | | | | - Sebastian Schmitter
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany
| | - Laura Boehmert
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
| | - Christian Prinz
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
| | - Hana Dobsicek Trefna
- Department of Electrical Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- MRI.TOOLS GmbH, Berlin, Germany
- Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| |
Collapse
|
16
|
Solving the Time- and Frequency-Multiplexed Problem of Constrained Radiofrequency Induced Hyperthermia. Cancers (Basel) 2020; 12:cancers12051072. [PMID: 32344914 PMCID: PMC7281622 DOI: 10.3390/cancers12051072] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 04/21/2020] [Accepted: 04/24/2020] [Indexed: 11/26/2022] Open
Abstract
Targeted radiofrequency (RF) heating induced hyperthermia has a wide range of applications, ranging from adjunct anti-cancer treatment to localized release of drugs. Focal RF heating is usually approached using time-consuming nonconvex optimization procedures or approximations, which significantly hampers its application. To address this limitation, this work presents an algorithm that recasts the problem as a semidefinite program and quickly solves it to global optimality, even for very large (human voxel) models. The target region and a desired RF power deposition pattern as well as constraints can be freely defined on a voxel level, and the optimum application RF frequencies and time-multiplexed RF excitations are automatically determined. 2D and 3D example applications conducted for test objects containing pure water (rtarget = 19 mm, frequency range: 500–2000 MHz) and for human brain models including brain tumors of various size (r1 = 20 mm, r2 = 30 mm, frequency range 100–1000 MHz) and locations (center, off-center, disjoint) demonstrate the applicability and capabilities of the proposed approach. Due to its high performance, the algorithm can solve typical clinical problems in a few seconds, making the presented approach ideally suited for interactive hyperthermia treatment planning, thermal dose and safety management, and the design, rapid evaluation, and comparison of RF applicator configurations.
Collapse
|
17
|
Paulides M, Dobsicek Trefna H, Curto S, Rodrigues D. Recent technological advancements in radiofrequency- andmicrowave-mediated hyperthermia for enhancing drug delivery. Adv Drug Deliv Rev 2020; 163-164:3-18. [PMID: 32229271 DOI: 10.1016/j.addr.2020.03.004] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Revised: 03/20/2020] [Accepted: 03/24/2020] [Indexed: 12/23/2022]
Abstract
Hyperthermia therapy is a potent enhancer of chemotherapy and radiotherapy. In particular, microwave (MW) and radiofrequency (RF) hyperthermia devices provide a variety of heating approaches that can treat most cancers regardless the size. This review introduces the physics of MW/RF hyperthermia, the current state-of-the-art systems for both localized and regional heating, and recent advancements in hyperthermia treatment guidance using real-time computational simulations and magnetic resonance thermometry. Clinical trials involving RF/MW hyperthermia as adjuvant for chemotherapy are also presented per anatomical site. These studies favor the use of adjuvant hyperthermia since it significantly improves curative and palliative clinical outcomes. The main challenge of hyperthermia is the distribution of state-of-the-art heating systems. Nevertheless, we anticipate that recent technology advances will expand the use of hyperthermia to chemotherapy centers for enhanced drug delivery. These new technologies hold great promise not only for (image-guided) perfusion modulation and sensitization for cytotoxic drugs, but also for local delivery of various compounds using thermosensitive liposomes.
Collapse
|
18
|
Oberacker E, Kuehne A, Oezerdem C, Nadobny J, Weihrauch M, Beck M, Zschaeck S, Diesch C, Eigentler TW, Waiczies H, Ghadjar P, Wust P, Winter L, Niendorf T. Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla). Int J Hyperthermia 2020; 37:549-563. [PMID: 32484019 PMCID: PMC8352381 DOI: 10.1080/02656736.2020.1761462] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Revised: 04/02/2020] [Accepted: 04/17/2020] [Indexed: 12/28/2022] Open
Abstract
Purpose: Thermal intervention is a potent sensitizer of cells to chemo- and radiotherapy in cancer treatment. Glioblastoma multiforme (GBM) is a potential clinical target, given the cancer's aggressive nature and resistance to current treatment options. The annular phased array (APA) technique employing electromagnetic waves in the radiofrequency (RF) range allows for localized temperature increase in deep seated target volumes (TVs). Reports on clinical applications of the APA technique in the brain are still missing. Ultrahigh field magnetic resonance (MR) employs higher frequencies than conventional MR and has potential to provide focal temperature manipulation, high resolution imaging and noninvasive temperature monitoring using an integrated RF applicator (ThermalMR). This work examines the applicability of RF applicator concepts for ThermalMR of brain tumors at 297 MHz (7.0 Tesla).Methods: Electromagnetic field (EMF) simulations are performed for clinically realistic data based on GBM patients. Two algorithms are used for specific RF energy absorption rate based thermal intervention planning for small and large TVs in the brain, aiming at maximum RF power deposition or RF power uniformity in the TV for 10 RF applicator designs.Results: For both TVs , the power optimization outperformed the uniformity optimization. The best results for the small TV are obtained for the 16 element interleaved RF applicator using an elliptical antenna arrangement with water bolus. The two row elliptical RF applicator yielded the best result for the large TV.Discussion: This work investigates the capacity of ThermalMR to achieve targeted thermal interventions in model systems resembling human brain tissue and brain tumors.
Collapse
Affiliation(s)
- Eva Oberacker
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Department of Physics, Faculty of Mathematics and Natural Sciences, Humboldt-Universität zu Berlin, Berlin, Germany
| | | | - Celal Oezerdem
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Experimental and Clinical Research Center (ECRC), Joint Cooperation Between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Jacek Nadobny
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
| | - Mirko Weihrauch
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
| | - Marcus Beck
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
| | - Sebastian Zschaeck
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
- Berlin Institute of Health (BIH), Berlin, Germany
| | - Cecilia Diesch
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Thomas Wilhelm Eigentler
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Chair of Medical Engineering, Technische Universität Berlin, Berlin, Germany
| | | | - Pirus Ghadjar
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
| | - Peter Wust
- Clinic for Radiation Oncology, Charité Universitätsmedizin, Berlin, Germany
| | - Lukas Winter
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Physikalisch Technische Bundesanstalt, Braunschweig, Germany
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- MRI.TOOLS GmbH, Berlin, Germany
- Experimental and Clinical Research Center (ECRC), Joint Cooperation Between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| |
Collapse
|
19
|
Niendorf T, Schulz-Menger J, Paul K, Huelnhagen T, Ferrari VA, Hodge R. High Field Cardiac Magnetic Resonance Imaging: A Case for Ultrahigh Field Cardiac Magnetic Resonance. Circ Cardiovasc Imaging 2019; 10:CIRCIMAGING.116.005460. [PMID: 28611118 DOI: 10.1161/circimaging.116.005460] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Thoralf Niendorf
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.).
| | - Jeanette Schulz-Menger
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.)
| | - Katharina Paul
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.)
| | - Till Huelnhagen
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.)
| | - Victor A Ferrari
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.)
| | - Russell Hodge
- From the Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (T.N., K.P., T.H., R.H.); DZHK (German Centre for Cardiovascular Research), partner site Berlin (T.N., J.S.-M.); Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (J.S.-M.); Department for Cardiology and Nephrology, HELIOS Clinic Berlin-Buch, Germany (J.S.-M.); and Division of Cardiovascular Medicine and Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (V.A.F.)
| |
Collapse
|
20
|
Alphandéry E. Glioblastoma Treatments: An Account of Recent Industrial Developments. Front Pharmacol 2018; 9:879. [PMID: 30271342 PMCID: PMC6147115 DOI: 10.3389/fphar.2018.00879] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Accepted: 07/20/2018] [Indexed: 12/28/2022] Open
Abstract
The different drugs and medical devices, which are commercialized or under industrial development for glioblastoma treatment, are reviewed. Their different modes of action are analyzed with a distinction being made between the effects of radiation, the targeting of specific parts of glioma cells, and immunotherapy. Most of them are still at a too early stage of development to firmly conclude about their efficacy. Optune, which triggers antitumor activity by blocking the mitosis of glioma cells under the application of an alternating electric field, seems to be the only recently developed therapy with some efficacy reported on a large number of GBM patients. The need for early GBM diagnosis is emphasized since it could enable the treatment of GBM tumors of small sizes, possibly easier to eradicate than larger tumors. Ways to improve clinical protocols by strengthening preclinical studies using of a broader range of different animal and tumor models are also underlined. Issues related with efficient drug delivery and crossing of blood brain barrier are discussed. Finally societal and economic aspects are described with a presentation of the orphan drug status that can accelerate the development of GBM therapies, patents protecting various GBM treatments, the different actors tackling GBM disease, the cost of GBM treatments, GBM market figures, and a financial analysis of the different companies involved in the development of GBM therapies.
Collapse
Affiliation(s)
- Edouard Alphandéry
- Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, UMR 7590 CNRS, Sorbonne Universités, UPMC, University Paris 06, Paris, France.,Nanobacterie SARL, Paris, France
| |
Collapse
|
21
|
Ji Y, Hoffmann W, Pham M, Dunn AE, Han H, Özerdem C, Waiczies H, Rohloff M, Endemann B, Boyer C, Lim M, Niendorf T, Winter L. High peak and high average radiofrequency power transmit/receive switch for thermal magnetic resonance. Magn Reson Med 2018; 80:2246-2255. [PMID: 29607551 DOI: 10.1002/mrm.27194] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2017] [Revised: 02/05/2018] [Accepted: 03/06/2018] [Indexed: 12/20/2022]
Abstract
PURPOSE To study the role of temperature in biological systems, diagnostic contrasts and thermal therapies, RF pulses for MR spin excitation can be deliberately used to apply a thermal stimulus. This application requires dedicated transmit/receive (Tx/Rx) switches that support high peak powers for MRI and high average powers for RF heating. To meet this goal, we propose a high-performance Tx/Rx switch based on positive-intrinsic-negative diodes and quarter-wavelength (λ/4) stubs. METHODS The λ/4 stubs in the proposed Tx/Rx switch design route the transmitted RF signal directly to the RF coil/antenna without passing through any electronic components (e.g., positive-intrinsic-negative diodes). Bench measurements, MRI, MR thermometry, and RF heating experiments were performed at f = 297 MHz (B0 = 7 T) to examine the characteristics and applicability of the switch. RESULTS The proposed design provided an isolation of -35.7dB/-41.5dB during transmission/reception. The insertion loss was -0.41dB/-0.27dB during transmission/reception. The switch supports high peak (3.9 kW) and high average (120 W) RF powers for MRI and RF heating at f = 297 MHz. High-resolution MRI of the wrist yielded image quality competitive with that obtained with a conventional Tx/Rx switch. Radiofrequency heating in phantom monitored by MR thermometry demonstrated the switch applicability for thermal modulation. Upon these findings, thermally activated release of a model drug attached to thermoresponsive polymers was demonstrated. CONCLUSION The high-power Tx/Rx switch enables thermal MR applications at 7 T, contributing to the study of the role of temperature in biological systems and diseases. All design files of the switch will be made available open source at www.opensourceimaging.org.
Collapse
Affiliation(s)
- Yiyi Ji
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | | | - Michal Pham
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Alexander E Dunn
- School of Chemical Engineering, The University of New South Wales, Sydney, Australia
| | - Haopeng Han
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Celal Özerdem
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | | | - Michael Rohloff
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Beate Endemann
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Cyrille Boyer
- School of Chemical Engineering, The University of New South Wales, Sydney, Australia
| | - May Lim
- School of Chemical Engineering, The University of New South Wales, Sydney, Australia
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.,Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Lukas Winter
- Berlin Ultrahigh Field Facility, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| |
Collapse
|
22
|
Guérin B, Villena JF, Polimeridis AG, Adalsteinsson E, Daniel L, White JK, Rosen BR, Wald LL. Computation of ultimate SAR amplification factors for radiofrequency hyperthermia in non-uniform body models: impact of frequency and tumour location. Int J Hyperthermia 2018; 34:87-100. [PMID: 28540815 PMCID: PMC5681886 DOI: 10.1080/02656736.2017.1319077] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 04/10/2017] [Accepted: 04/10/2017] [Indexed: 10/19/2022] Open
Abstract
PURPOSE We introduce a method for calculation of the ultimate specific absorption rate (SAR) amplification factors (uSAF) in non-uniform body models. The uSAF is the greatest possible SAF achievable by any hyperthermia (HT) phased array for a given frequency, body model and target heating volume. METHODS First, we generate a basis-set of solutions to Maxwell's equations inside the body model. We place a large number of electric and magnetic dipoles around the body model and excite them with random amplitudes and phases. We then compute the electric fields created in the body model by these excitations using an ultra-fast volume integral solver called MARIE. We express the field pattern that maximises the SAF in the target tumour as a linear combination of these basis fields and optimise the combination weights so as to maximise SAF (concave problem). We compute the uSAFs in the Duke body models at 10 frequencies in the 20-900 MHz range and for twelve 3 cm-diameter tumours located at various depths in the head and neck. RESULTS For both shallow and deep tumours, the frequency yielding the greatest uSAF was ∼900 MHz. Since this is the greatest frequency that we simulated, we hypothesise that the globally optimal frequency is actually greater. CONCLUSIONS The uSAFs computed in this work are very large (40-100 for shallow tumours and 4-17 for deep tumours), indicating that there is a large room for improvement of the current state-of-the-art head and neck HT devices.
Collapse
Affiliation(s)
- Bastien Guérin
- a Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA
- b Harvard Medical School , Boston , MA , USA
| | | | | | - Elfar Adalsteinsson
- e Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA
- f Harvard-MIT Division of Health Sciences Technology , Cambridge , MA , USA
| | - Luca Daniel
- e Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA
| | - Jacob K White
- e Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA
| | - Bruce R Rosen
- a Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA
- b Harvard Medical School , Boston , MA , USA
- f Harvard-MIT Division of Health Sciences Technology , Cambridge , MA , USA
| | - Lawrence L Wald
- a Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA
- b Harvard Medical School , Boston , MA , USA
- f Harvard-MIT Division of Health Sciences Technology , Cambridge , MA , USA
| |
Collapse
|
23
|
Adibzadeh F, Paulides MM, van Rhoon GC. SAR thresholds for electromagnetic exposure using functional thermal dose limits. Int J Hyperthermia 2018; 34:1248-1254. [DOI: 10.1080/02656736.2018.1424945] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- Fatemeh Adibzadeh
- Department of Radiation Oncology, Hyperthermia Unit, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands
| | - Margarethus M. Paulides
- Department of Radiation Oncology, Hyperthermia Unit, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands
| | - Gerard C. van Rhoon
- Department of Radiation Oncology, Hyperthermia Unit, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands
| |
Collapse
|
24
|
Han H, Moritz R, Oberacker E, Waiczies H, Niendorf T, Winter L. Open Source 3D Multipurpose Measurement System with Submillimetre Fidelity and First Application in Magnetic Resonance. Sci Rep 2017; 7:13452. [PMID: 29044156 PMCID: PMC5647334 DOI: 10.1038/s41598-017-13824-z] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 09/29/2017] [Indexed: 12/12/2022] Open
Abstract
Magnetic resonance imaging (MRI) is the mainstay of diagnostic imaging, a versatile instrument for clinical science and the subject of intense research interest. Advancing clinical science, research and technology of MRI requires high fidelity measurements in quantity, location and time of the given physical property. To meet this goal a broad spectrum of commercial measurement systems has been made available. These instruments frequently share in common that they are costly and typically employ closed proprietary hardware and software. This shortcoming makes any adjustment for a specified application difficult if not prohibitive. Recognizing this limitation this work presents COSI Measure, an automated open source measurement system that provides submillimetre resolution, robust configuration and a large working volume to support a versatile range of applications. The submillimetre fidelity and reproducibility/backlash performance were evaluated experimentally. Magnetic field mapping of a single ring Halbach magnet, a 3.0 T and a 7.0 T MR scanner as well as temperature mapping of a radio frequency coil were successfully conducted. Due to its open source nature and versatile construction, the system can be easily modified for other applications. In a resource limited research setting, COSI Measure makes efficient use of laboratory space, financial resources and collaborative efforts.
Collapse
Affiliation(s)
- Haopeng Han
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Raphael Moritz
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Eva Oberacker
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | | | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité and the Max Delbrück Center for Molecular Medicine, Berlin, Germany
- MRI.TOOLS GmbH, Berlin, Germany
| | - Lukas Winter
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
| |
Collapse
|
25
|
Niendorf T, Barth M, Kober F, Trattnig S. From ultrahigh to extreme field magnetic resonance: where physics, biology and medicine meet. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE 2017; 29:309-11. [PMID: 27221262 DOI: 10.1007/s10334-016-0564-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Thoralf Niendorf
- Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association, Robert Roessle Strasse 10, 13125, Berlin, Germany.
| | - Markus Barth
- Centre for Advanced Imaging, The University of Queensland, Building 57, Research Road, St Lucia, QLD, 4072, Australia
| | - Frank Kober
- Centre de Résonance Magnétique Biologique et Médicale (CRMBM), Aix-Marseille Université, CNRS UMR7339, 13385, Marseille Cedex 05, France
| | - Siegfried Trattnig
- High Field MR Center, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria
| |
Collapse
|
26
|
Paulides MM, Mestrom RMC, Salim G, Adela BB, Numan WCM, Drizdal T, Yeo DTB, Smolders AB. A printed Yagi-Uda antenna for application in magnetic resonance thermometry guided microwave hyperthermia applicators. Phys Med Biol 2017; 62:1831-1847. [PMID: 28052042 DOI: 10.1088/1361-6560/aa56b3] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Biological studies and clinical trials show that addition of hyperthermia stimulates conventional cancer treatment modalities and significantly improves treatment outcome. This supra-additive stimulation can be optimized by adaptive hyperthermia to counteract strong and dynamic thermoregulation. The only clinically proven method for the 3D non-invasive temperature monitoring required is by magnetic resonance (MR) temperature imaging, but the currently available set of MR compatible hyperthermia applicators lack the degree of heat control required. In this work, we present the design and validation of a high-frequency (433 MHz ISM band) printed circuit board antenna with a very low MR-footprint. This design is ideally suited for use in a range of hyperthermia applicator configurations. Experiments emulating the clinical situation show excellent matching properties of the antenna over a 7.2% bandwidth (S 11 < -15 dB). Its strongly directional radiation properties minimize inter-element coupling for typical array configurations (S 21 < -23 dB). MR imaging distortion by the antenna was found negligible and MR temperature imaging in a homogeneous muscle phantom was highly correlated with gold-standard probe measurements (root mean square error: RMSE = 0.51 °C and R 2 = 0.99). This work paves the way for tailored MR imaging guided hyperthermia devices ranging from single antenna or incoherent antenna-arrays, to real-time adaptive hyperthermia with phased-arrays.
Collapse
Affiliation(s)
- M M Paulides
- Department of Radiation Oncology, Erasmus University Medical Center, Cancer Institute, Rotterdam, Netherlands
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Budinger TF, Bird MD, Frydman L, Long JR, Mareci TH, Rooney WD, Rosen B, Schenck JF, Schepkin VD, Sherry AD, Sodickson DK, Springer CS, Thulborn KR, Uğurbil K, Wald LL. Toward 20 T magnetic resonance for human brain studies: opportunities for discovery and neuroscience rationale. MAGMA (NEW YORK, N.Y.) 2016; 29:617-39. [PMID: 27194154 PMCID: PMC5538368 DOI: 10.1007/s10334-016-0561-4] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Revised: 04/06/2016] [Accepted: 04/11/2016] [Indexed: 12/16/2022]
Abstract
An initiative to design and build magnetic resonance imaging (MRI) and spectroscopy (MRS) instruments at 14 T and beyond to 20 T has been underway since 2012. This initiative has been supported by 22 interested participants from the USA and Europe, of which 15 are authors of this review. Advances in high temperature superconductor materials, advances in cryocooling engineering, prospects for non-persistent mode stable magnets, and experiences gained from large-bore, high-field magnet engineering for the nuclear fusion endeavors support the feasibility of a human brain MRI and MRS system with 1 ppm homogeneity over at least a 16-cm diameter volume and a bore size of 68 cm. Twelve neuroscience opportunities are presented as well as an analysis of the biophysical and physiological effects to be investigated before exposing human subjects to the high fields of 14 T and beyond.
Collapse
Affiliation(s)
- Thomas F Budinger
- Lawrence Berkeley National Laboratory, University of California, Berkeley, CA, USA.
| | - Mark D Bird
- National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, USA
| | - Lucio Frydman
- National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, USA
- Weizmann Institute, Rehovot, Israel
| | - Joanna R Long
- McKnight Brain Institute, University of Florida, Gainesville, FL, USA
| | - Thomas H Mareci
- McKnight Brain Institute, University of Florida, Gainesville, FL, USA
| | | | - Bruce Rosen
- Massachusetts General Hospital, Harvard Medical School, Harvard, MA, USA
| | - John F Schenck
- General Electric Corporate Research, Schenectady, NY, USA
| | - Victor D Schepkin
- National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, USA
| | - A Dean Sherry
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | | | | | | | | | - Lawrence L Wald
- Massachusetts General Hospital, Harvard Medical School, Harvard, MA, USA
| |
Collapse
|
28
|
Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE 2016; 29:641-56. [PMID: 27097905 DOI: 10.1007/s10334-016-0559-y] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Revised: 04/04/2016] [Accepted: 04/06/2016] [Indexed: 10/21/2022]
Abstract
OBJECTIVE This work investigates electrodynamic constraints, explores RF antenna concepts and examines the transmission fields (B 1 (+) ) and RF power deposition of dipole antenna arrays for (1)H magnetic resonance of the human brain at 1 GHz (23.5 T). MATERIALS AND METHODS Electromagnetic field (EMF) simulations are performed in phantoms with average tissue simulants for dipole antennae using discrete frequencies [300 MHz (7.0 T) to 3 GHz (70.0 T)]. To advance to a human setup EMF simulations are conducted in anatomical human voxel models of the human head using a 20-element dipole array operating at 1 GHz. RESULTS Our results demonstrate that transmission fields suitable for (1)H MR of the human brain can be achieved at 1 GHz. An increase in transmit channel density around the human head helps to enhance B 1 (+) in the center of the brain. The calculated relative increase in specific absorption rate at 23.5 versus 7.0 T was below 1.4 (in-phase phase setting) and 2.7 (circular polarized phase setting) for the dipole antennae array. CONCLUSION The benefits of multi-channel dipole antennae at higher frequencies render MR at 23.5 T feasible from an electrodynamic standpoint. This very preliminary finding opens the door on further explorations that might be catalyzed into a 20-T class human MR system.
Collapse
|
29
|
Paulides MM, Verduijn GM, Van Holthe N. Status quo and directions in deep head and neck hyperthermia. Radiat Oncol 2016; 11:21. [PMID: 26868027 PMCID: PMC4751675 DOI: 10.1186/s13014-016-0588-8] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2015] [Accepted: 01/13/2016] [Indexed: 12/18/2022] Open
Abstract
The benefit of hyperthermia as a potent modifier of radiotherapy has been well established and more recently also the combination with chemotherapy was shown beneficial. Also for head and neck cancer, the impact of hyperthermia has been clinically demonstrated by a number of clinical trials. Unfortunately, the technology applied in these studies provided only limited thermal dose control, and the devices used only allowed treatment of target regions close to the skin. Over the last decade, we developed the technology for deep and controlled hyperthermia that allows treatment of the entire head and neck region. Our strategy involves focused microwave heating combined with 3D patient-specific electromagnetic and thermal simulations for conformal, reproducible and adaptive hyperthermia application. Validation of our strategy has been performed by 3D thermal dose assessment based on invasively placed temperature sensors combined with the 3D patient specific simulations. In this paper, we review the phase III clinical evidence for hyperthermia in head and neck tumors, as well as the heating and dosimetry technology applied in these studies. Next, we describe the development, clinical implementation and validation of 3D guided deep hyperthermia with the HYPERcollar, and its second generation, i.e. the HYPERcollar3D. Lastly, we discuss early clinical results and provide an outlook for this technology.
Collapse
Affiliation(s)
| | - Gerda M Verduijn
- Erasmus MC Cancer Institute, Box 5201, 3008AE, Rotterdam, The Netherlands.
| | - Netteke Van Holthe
- Erasmus MC Cancer Institute, Box 5201, 3008AE, Rotterdam, The Netherlands.
| |
Collapse
|
30
|
Winter L, Oberacker E, Paul K, Ji Y, Oezerdem C, Ghadjar P, Thieme A, Budach V, Wust P, Niendorf T. Magnetic resonance thermometry: Methodology, pitfalls and practical solutions. Int J Hyperthermia 2015; 32:63-75. [DOI: 10.3109/02656736.2015.1108462] [Citation(s) in RCA: 132] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
|